Why Watermark is short Aussie healthcare


The big news out of recent US healthcare earnings was slowing revenue growth, due to funders of healthcare trying to rein in their budgets. Fund managers starved of growth options are inflating the value of Australian healthcare stocks and will face a shock when revenue growth is hit by falling prices, as is playing out in the United States, analyst Nick Cameron says.



from Biotech News